Brief: Nordic Nanovector ASA Announces Ludvik Sandnes Has Been Appointed Interim CEO And CFO
Jan 31 (Reuters) - Nordic Nanovector ASA NANOVN.OL :
* ANNOUNCES THAT LUDVIK SANDNES HAS BEEN APPOINTED INTERIM
CHIEF
EXECUTIVE OFFICER (CEO) AND CHIEF FINANCIAL OFFICER (CFO)
* LUDVIK SANDNES HAS BEEN APPOINTED INTERIM CEO AND CFO OF
COMPANY
AS FROM 1 FEBRUARY 2023
* CONFIRMS THAT ITS STAND-ALONE CASH POSITION AT END
DECEMBER 2022
IS EXPECTED TO BE APPROXIMATELY NOK 98M
Source text for Eikon: ID:nWkr1bDfhN
Further company coverage: NANOVN.OL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln